相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Proteasome Addiction Defined in Ewing Sarcoma Is Effectively Targeted by a Novel Class of 19S Proteasome Inhibitors
Neerav Shukla et al.
CANCER RESEARCH (2016)
The proteasome deubiquitinase inhibitor VLX1570 shows selectivity for ubiquitin-specific protease-14 and induces apoptosis of multiple myeloma cells
Xin Wang et al.
SCIENTIFIC REPORTS (2016)
Outcomes of patients with chronic lymphocytic leukemia after discontinuing ibrutinib
Preetesh Jain et al.
BLOOD (2015)
Targeted inhibition of the deubiquitinating enzymes, USP14 and UCHL5, induces proteotoxic stress and apoptosis in Waldenstroom macroglobulinaemia tumour cells
Kasyapa Chitta et al.
BRITISH JOURNAL OF HAEMATOLOGY (2015)
Synthesis and Evaluation of Derivatives of the Proteasome Deubiquitinase Inhibitor b-AP15
Xin Wang et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2015)
MYD88 Mutations and Response to Ibrutinib in Waldenstrom's Macroglobulinemia
Steven P. Treon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Ibrutinib in Previously Treated Waldenstrom's Macroglobulinemia
Steven P. Treon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Simultaneous inhibition of deubiquitinating enzymes (DUBs) and autophagy synergistically kills breast cancer cells
Rachel Isaksson Vogel et al.
ONCOTARGET (2015)
CXCR4 WHIM-like frameshift and nonsense mutations promote ibrutinib resistance but do not supplant MYD88L265P-directed survival signalling in Waldenstrom macroglobulinaemia cells
Yang Cao et al.
BRITISH JOURNAL OF HAEMATOLOGY (2015)
The WHIM-like CXCR4S338X somatic mutation activates AKT and ERK, and promotes resistance to ibrutinib and other agents used in the treatment of Waldenstrom's Macroglobulinemia
Y. Cao et al.
LEUKEMIA (2015)
Induction of Tumor Cell Apoptosis by a Proteasome Deubiquitinase Inhibitor Is Associated with Oxidative Stress
Slavica Brnjic et al.
ANTIOXIDANTS & REDOX SIGNALING (2014)
A novel small molecule inhibitor of deubiquitylating enzyme USP14 and UCHL5 induces apoptosis in multiple myeloma and overcomes bortezomib resistance
Ze Tian et al.
BLOOD (2014)
CXCR7-dependent angiogenic mononuclear cell trafficking regulates tumor progression in multiple myeloma
Abdel Kareem Azab et al.
BLOOD (2014)
AT-101 downregulates BCL2 and MCL1 and potentiates the cytotoxic effects of lenalidomide and dexamethasone in preclinical models of multiple myeloma and Waldenstrom macroglobulinaemia
Aneel Paulus et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
lbrutinib Treatment of CLL: The Cancer Fights Back
Ryan M. Young et al.
CANCER CELL (2014)
Proapoptotic effects of the novel proteasome inhibitor b-AP15 on multiple myeloma cells and natural killer cells
Xiaoli Feng et al.
EXPERIMENTAL HEMATOLOGY (2014)
Regulation of TRAIL-Receptor Expression by the Ubiquitin-Proteasome System
Dhifaf Sarhan et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)
Neem leaf extract induces cell death by apoptosis and autophagy in B-chronic lymphocytic leukemia cells
Kasyapa S. Chitta et al.
LEUKEMIA & LYMPHOMA (2014)
Resistance Mechanisms for the Bruton's Tyrosine Kinase Inhibitor Ibrutinib
Jennifer A. Woyach et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Ibrutinib Resistance in Chronic Lymphocytic Leukemia
Richard R. Furman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Crystal structure of the proteasomal deubiquitylation module Rpn8-Rpn11
Ganesh Ramnath Pathare et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Nimbolide targets BCL2 and induces apoptosis in preclinical models of Waldenstroms macroglobulinemia
K. Chitta et al.
BLOOD CANCER JOURNAL (2014)
Cell-Cycle Reprogramming for PI3K Inhibition Overrides a Relapse-Specific C481S BTK Mutation Revealed by Longitudinal Functional Genomics in Mantle Cell Lymphoma
David Chiron et al.
CANCER DISCOVERY (2014)
The 19S Deubiquitinase Inhibitor b-AP15 Is Enriched in Cells and Elicits Rapid Commitment to Cell Death
Xin Wang et al.
MOLECULAR PHARMACOLOGY (2014)
A novel inhibitor of proteasome deubiquitinating activity renders tumor cells sensitive to TRAIL-mediated apoptosis by natural killer cells and T cells
Dhifaf Sarhan et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
Proteasome Inhibitor Therapy for Waldenstrom's Macroglobulinemia
Meletios A. Dimopoulos et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2013)
Development and characterization of a novel human Waldenstrom macroglobulinemia cell line: RPCI-WM1, Roswell Park Cancer Institute - Waldenstrom Macroglobulinemia 1
Kasyapa S. Chitta et al.
LEUKEMIA & LYMPHOMA (2013)
Would the real Waldenstrom cell line please stand up?
Hans G. Drexler et al.
LEUKEMIA & LYMPHOMA (2013)
Targeting pathological B cell receptor signalling in lymphoid malignancies
Ryan M. Young et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
Proteasome deubiquitinases as novel targets for cancer therapy
Padraig D'Arcy et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2012)
Waldenstrom macroglobulinemia: a Surveillance, Epidemiology, and End Results database review from 1988 to 2005
Jeevan Sekhar et al.
LEUKEMIA & LYMPHOMA (2012)
Deubiquitinases in cancer: new functions and therapeutic options
J. M. Fraile et al.
ONCOGENE (2012)
Proteasome Inhibition and Combination Therapy for Non-Hodgkin's Lymphoma: From Bench to Bedside
Anthony R. Mato et al.
ONCOLOGIST (2012)
Effect of ubiquitin carboxy-terminal hydrolase 37 on apoptotic in A549 cells
Zhiwei Chen et al.
CELL BIOCHEMISTRY AND FUNCTION (2011)
Inhibition of proteasome deubiquitinating activity as a new cancer therapy
Padraig D'Arcy et al.
NATURE MEDICINE (2011)
Phase II Trial of Weekly Bortezomib in Combination With Rituximab in Relapsed or Relapsed and Refractory Waldenstrom Macroglobulinemia
Irene M. Ghobrial et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Ontology-Based Meta-Analysis of Global Collections of High-Throughput Public Data
Ilya Kupershmidt et al.
PLOS ONE (2010)
Vascular complications after splenectomy for hematologic disorders
Shelley E. Crary et al.
BLOOD (2009)
Deubiquitination of CXCR4 by USP14 Is Critical for Both CXCL12-induced CXCR4 Degradation and Chemotaxis but Not ERK Activation
Marjelo A. Mines et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
SDF-1/CXCR4 and VLA-4 interaction regulates homing in Waldenstrom macroglobulinemia
Hai T. Ngo et al.
BLOOD (2008)
Proteasome-dependent autoregulation of Bruton tyrosine kinase (Btk) promoter via NF-κB
Liang Yu et al.
BLOOD (2008)
Signal integration in the endoplasmic reticulum unfolded protein response
David Ron et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Multicenter clinical trial of bortezomib in relapsed/refractory Waldenstrom's macroglobulinemia: Results of WMCTG trial 03-248
Steven P. Treon et al.
CLINICAL CANCER RESEARCH (2007)
Mitochondrial membrane permeabilization in cell death
Guido Kroemer et al.
PHYSIOLOGICAL REVIEWS (2007)
Proteasome inhibitor bortezomib modulates TLR4-induced dendritic cell activation
Alessio Nencioni et al.
BLOOD (2006)
Activity profiling of deubiquitinating enzymes in cervical carcinoma biopsies and cell lines
U Rolén et al.
MOLECULAR CARCINOGENESIS (2006)
NF-κB promotes breast cancer cell migration and metastasis by inducing the expression of the chemokine receptor CXCR4
G Helbig et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
The proteasome: structure, function, and role in the cell
J Adams
CANCER TREATMENT REVIEWS (2003)
分享论文
